Ann: Mesoblast Phase 3 Chronic Low Back Pain Results, page-261

okay so I've just spoken to Mesoblast Investor relations on the telephone and they confirmed the the primary endpoint was not met. I asked them to feedback that this was not communicated effectively and that it looks like it was deliberately hidden from the investors which in my view in unethical and significantly reduces my confidence in the honesty and integrity of the management team. shocking behaviour in my view regardless of the positive secondary data in my view. Very disappointed in Si and his team. that is all.